Hyundai Motor Company today announced a bold roadmap to secure its position as a frontrunner in the future mobility industry.
Under the new roadmap, named Strategy 2025, the company will foster Smart Mobility Device and Smart Mobility Service as two core business pillars, and the synergy between the two pillars is expected to facilitate the company’s transition into a Smart Mobility Solution Provider.
The Smart Mobility Device business will supply products optimized for the services and lay the groundwork to help foster the service business. On the other hand, the Smart Mobility Service business will provide personalized contents and services on the devices to help secure a broader customer base.
Hyundai’s plans for Smart Mobility Device include a wide range of product groups beyond automobiles such as Personal Air Vehicle (PAV), robotics, and last-mile mobility. Hyundai will reinforce its manufacturing capabilities to build products that offer customers a seamless mobility experience.
*Hyundai Motor will develop Urban Air Mobility (UAM) platform business by combining Personal Air Vehicle (PAV) and mobility services.
Smart Mobility Service is a new area of business for Hyundai that will be fostered as a key strategic pillar for future businesses. Services and contents will be personalized and offered through an integrated platform to maximize value for customers.
The two pillars sit atop three key directions that the company has defined: enhancing profitability in internal combustion engine (ICE) vehicles, securing leadership in vehicle electrification, and laying the groundwork for platform-based businesses.
To materialize Strategy 2025 on the Device side, Hyundai will aim for growth that is balanced and steady, seeking balance between markets as well as models while prioritizing long-term sustainability over short-term targets. The company also plans to boost profitability by simultaneously pursuing enhanced value for customers and innovations in cost structures.
In particular, Hyundai aims to secure leadership in electrification by selling 670,000 electric vehicles annually and become one of the world’s top three manufacturers of battery and fuel cell EVs by 2025.
On the Smart Mobility Service side, the company will aim for a business model that combines product and service and launch an integrated mobility platform to offer customers personalized contents and services.
To this end, Hyundai will earmark KRW 61.1 trillion of investment until 2025 for research and development (R&D) and further exploration of future technologies. In the same timeframe, the company will target an operating margin of 8 percent in its automotive business and aim for a 5 percent share of the global vehicle market.
Separately, Hyundai announced plans to conduct a KRW 300 billion share buyback by February 2020 as part of its continuous efforts to boost shareholder and stakeholder value and enhance transparent communication with the market.
Hyundai’s comprehensive mid- to long-term strategic direction was presented by the company’s President and CEO Wonhee Lee during the “CEO Investor Day” forum held today in Seoul, which was attended by various stakeholders including shareholders and investors.
“The key to our future strategy is to focus on customers and to present the most desirable products and services. We want to offer smart mobility experiences that meet shifting needs of our customers by leveraging advanced technology,” said President Lee. “Transforming into a Smart Mobility Solution Provider with comprehensive mobility solutions that combine devices and services will be the centerpiece of Hyundai’s future strategy”
(1) Smart Mobility Device
In the Smart Mobility Device domain, Hyundai has set out strategies to maintain its competitiveness in the core manufacturing business by bolstering profitability in ICE vehicles and securing leadership in electrification.
The company plans to achieve balanced and steady growth with a portfolio that takes into account various regional and product needs.
In particular, Hyundai will address vehicle electrification by first targeting younger demographics and enterprise customers with affordable battery electric vehicles (BEVs) to achieve economies of scale. By 2025, the company aims to sell 670,000 electric vehicles annually, comprising 560,000 BEVs and 110,000 fuel-cell electric vehicles (FCEVs). The goal is to electrify most new models by 2030 in key markets such as Korea, US, China, and Europe, with emerging markets such as India and Brazil following suit by 2035.
The Genesis brand will launch its first fully-electric models in 2021, before expanding its electric lineup in 2024. The high-performance N brand also plans to launch SUVs and EVs, further boosting Hyundai’s competitiveness in electrification.
The company will also simultaneously implement quality and cost innovations to enhance customer value while innovating cost structures.
Quality innovations will maximize customer value based on three smart elements: innovative digital user experience (UX), artificial intelligence (AI) based connected services, and safety-first autonomous driving. With regards to autonomous driving technology, SAE Level 2 and 3, as well as Advanced Driver Assistance System (ADAS) for parking, will be available in all models by 2025, alongside the company’s aim to develop a full autonomous driving platform by 2022 and begin mass production by 2024. Hyundai’s plan to offer differentiated vehicle features to customers is expected to reduce incentive spending and improve customer perception of the brand.
For cost innovation, the company will adopt a new global modular EV architecture to enhance efficiency and scalability of product development, starting with vehicles being launched in 2024. The company also has plans to revamp its sales model through network optimization and new sales methods, to optimize production based on demand, and to expand partnerships with other OEMs.
(2) Smart Mobility Service
Smart Mobility Service will be a key future growth driver for Hyundai, bringing together device and service to offer customers a personalized mobility lifestyle.
The company plans to leverage its existing customer base to provide services linked to vehicles, including maintenance, repair, financing, insurance, and charging. It will also make efforts to reach a broader group of customers with a more comprehensive range of services. Hyundai will build an integrated mobility platform that analyzes data from in and around the vehicle through car connectivity. Through an enhanced understanding of customers, the company will offer services tailored to the needs of customers in every aspect of their lives, including shopping, delivery, streaming, and multi-modal mobility services.
Strategy 2025 also details regional optimization for Smart Mobility Service. In the US, car sharing and robotaxi service demonstrations will capitalize on the anticipated commercialization of autonomous vehicles of SAE Level 4 or higher. In Korea, Asia, and Australia, Hyundai plans to enter the mobility service market by partnering with leading local players. In Europe and Russia, where the service industry is mature, the company will first focus on businesses that combine products and services.
Organization and management reform plans are also in place for the successful implementation of Strategy 2025. The company will adopt new systems for data-based decision making, employee performance management, process innovation, and next-generation enterprise resource planning (ERP). It will also create a more flexible organizational structure and foster a harmonious corporate culture centered around communication and collaboration.
Hyundai also identified key financial targets required to achieve the goals outlined in Strategy 2025.
Over a six-year period from 2020 through 2025, the company will invest a total of KRW 61.1 trillion, or roughly KRW 10 trillion per year, in R&D and future core technologies to smooth its transition into a Smart Mobility Solution Provider. In particular, KRW 41.1 trillion will be allocated for product and capex to enhance competitiveness in existing businesses, while approximately KRW 20 trillion will be dedicated to future technologies including electrification, autonomous driving, AI, robotics, PAV, and new energy area.
The six-year investment plan has been refreshed and updated from the company’s existing plan – announced in February 2019 – under which the company disclosed a KRW 45.3 trillion spending plan in the 2019-2023 period.
Hyundai’s newly set target for operating profit margin in its automotive division stands at 8 percent by 2025, which rolls over from the previous target of 7 percent by 2022.
Supported by enhanced profitability and cost competitiveness, the company will increase the share of electrified vehicles in its product lineup and lay the groundwork for new mobility service businesses to reach this goal. The successful footprint of the Genesis brand in the global luxury vehicle market is also expected to further enhance the company’s profitability.
An array of cost innovation programs – such as platform integration, standardized vehicle architecture, and commonization of parts – will help boost efficiency in the company’s parts supply chain. Vehicle architecture processes will be optimized by region, and innovative manufacturing technologies will be implemented to further enhance efficiency and profitability.
An improved product mix, combined with competitive new models, will help reduce incentive spending, while pre-emptive quality control efforts will decrease quality-related costs. The company will also pursue increased investment efficiency for the Genesis brand.
Hyundai’s goal to achieve 5 percent market share in the global automotive industry by 2025 is a 1 percentage point increase from roughly 4 percent achieved in 2018. To meet this target, the company will address fluctuating demand in individual markets with regional flexibility and offer competitive mobility services.
Hyundai also announced plans to buy back KRW 300 billion worth of its own shares from the market by February next year as part of its continuous efforts to boost shareholder value and market-friendly policies.
Since first announcing plans to maximize shareholder return in 2014, the company’s dividend gradually increased to KRW 4,000 per share in 2015 compared to KRW 1,950 in 2013. In 2018, Hyundai executed a large-scale share buyback and cancel program, which applied to an equivalent of 3 percent of total outstanding shares.
“Hyundai will always prioritize its customers and strive to connect people’s lives with quality time,” said President Lee. “We will do our utmost to equip ourselves for the future, to lead the future mobility industry, and maximize shareholder value.”
United States Geospatial Analytics Market By Component, By Deployment Mode, By Type, By Application, By End User Industry, Competition, Forecast & Opportunities, 2025
New York, July 03, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “United States Geospatial Analytics Market By Component, By Deployment Mode, By Type, By Application, By End User Industry, Competition, Forecast & Opportunities, 2025” – https://www.reportlinker.com/p05916705/?utm_source=GNWClare: email@example.com
Intl: +1 339-368-6001
The robotic lawn mower market by revenue is expected to grow at a CAGR of over 12% during the period 2019–2025
New York, July 03, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Robotic Lawn Mowers Market – Global Outlook and Forecast 2020-2025” – https://www.reportlinker.com/p05779102/?utm_source=GNWClare: firstname.lastname@example.org
Intl: +1 339-368-6001
Healthcare Analytics Market Worth $84.2 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Estimates by Meticulous Research®
London, July 03, 2020 (GLOBE NEWSWIRE) — According to a new market research report “Healthcare Analytics Market by Type (Predictive, Prescriptive), Component (Hardware, Software, and Services), Delivery Mode (Cloud), Application (Clinical, RCM, Claims, Fraud, Risk, PHM), End user (Payer, Provider) and Geography- Global Forecast to 2027”, published by Meticulous Research®, the healthcare analytics market is expected to grow at a CAGR of 26% from 2020 to reach $84.2 billion by 2027.Download Free Sample Report Now @ https://www.meticulousresearch.com/request-sample-report/cp_id=3995 The healthcare analytics market is witnessing a consistent growth owing to the growing demand from population health management (PHM), need for redesigned EHRs with advanced analytics capabilities, growth in eHealth collaborative, growing investments by venture capitalists, increasing pressure to provide quality care and control healthcare costs, rising big data in healthcare, trend towards value-based care, improving HCIT infrastructure, and launch of COVID-19 specific analytics solutions. However, lack of data scientists/analytics skills, high price of analytics, and data integration and security challenges may hinder the growth of this market to some extent.The overall healthcare analytics market study presents historical market data in terms of values (2018 & 2019), estimated current data (2020), and forecasts for 2027 – by type (descriptive analytics, predictive analytics, and prescriptive analytics), component (services, software, and hardware), mode of delivery (on-premise, web-based, and cloud-based analytics models), application (financial analytics, clinical analytics, operational analytics & administrative analytics, and population health analytics), end-user (payers, providers, and Accountable Care Organizations (ACOs), and geography. The study also evaluates industry competitors and analyzes the market at a country level.Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3995Based on type, the descriptive analytics segment is estimated to command the largest share of the overall healthcare analytics market in 2020. Descriptive analytics forms the base for the effective application of predictive or prescription analytics.Based on component, the services segment is estimated to hold the largest share of the overall healthcare analytics market in 2020. This is primarily attributed to growing demand for cloud-based analytics, recurring need for support services, and lack of IT skills in healthcare industry.Based on mode of delivery, the on-premise analytics segment is estimated to hold the largest share of the overall healthcare analytics market in 2020. This is mainly due to concerns related to patient data confidentiality and security on remotely managed servers.Based on application, the financial analytics segment is estimated to command the largest share of the overall healthcare analytics market in 2020. This is mainly attributed to the growing adoption of analytics by the healthcare providers to reduce hospital re-admissions, curtail growing healthcare costs, and be eligible for value-based reimbursements.Based on end-user, the payer analytics segment is estimated to hold the largest share of the overall healthcare analytics market in 2020. This is mainly attributed to stringent government norms and high focus on fraud prevention, launch of payer analytics specific solutions that optimize productivity and reduce costs, and growing traction for analytics among employer groups.The healthcare analytics market scope varies greatly across different continents. The reason for this lies in the rate of technological developments in different parts of the world. North America region is estimated to command the largest share of the global healthcare analytics market in 2020 and is expected to maintain its dominance throughout the forecast period. This region is also expected to grow at the highest CAGR during the forecast period. The large share of this region is mainly attributed to the significant adoption of analytics in the U.S. post the implementation of Affordable Care Act (ACA) and impact of on-going COVID-19 pandemic, easy availability of analytics solutions in this region, prominent venture capital investments in the U.S., and significant government focus on population health management and value-based care.Quick Buy – Healthcare Analytics Market Research Report: https://www.meticulousresearch.com/buy_now.php?pformat=80&vformat=253The report also includes an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years. A majority of players in the healthcare analytics market are adopting key strategies such as strategic alliances, partnerships, collaborations, mergers and acquisitions, and new product/service developments to expand their product and service offerings, global footprint, and augment their market shares. For instance, in June 2020, SAS launched SAS Viya 4, an analytics tool for medical and healthcare sectors which is expected to be available in late 2020. The solution integrates artificial intelligence (AI) and analytics for improved decision-making. Similarly, in April 2020, Allscript’s business EPSi released a COVID-19 Planning Analytics tool that includes 5 independent analyses focused on answering the tough questions being asked by health system leaders. These include ICU capacity, financial burden of COVID-19, resumption of elective procedures, and cost-reduction.The global healthcare analytics market is highly fragmented and competitive in nature. Some of the leading players operating in the global healthcare analytics market are Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), Health Catalyst (U.S.), IBM Corporation (U.S.), Inovalon (U.S.), McKesson Corporation (U.S.), MedeAnalytics, Inc. (U.S.), Microsoft Corporation (U.S.), NextHealth Technologies (U.S.), UnitedHealthcare Group (U.S.), Oracle Corporation (U.S.), SAP SE (Germany), SAS Institute Inc. (U.S.), SCIOInspire, Corp. (U.S.), Tableau Software, Inc. (U.S.), TIBCO Software, Inc. (U.S.), Verscend Technologies, Inc. (U.S.), and VitreosHealth (U.S.), among others.To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/healthcare-analytics-market/Scope of the Report:Healthcare Analytics market, by Type Descriptive analyticsPredictive analyticsPrescriptive analytics Healthcare Analytics Market, by Component ServicesSupport ServicesBusiness Analytics Services Software Hardware Healthcare Analytics Market, by Mode of Delivery On-premiseWeb-basedCloud-based Healthcare Analytics Market, by Application Financial analyticsClaims analyticsRevenue Cycle ManagementPayment Integrity & Fraud, Waste & Abuse (FWA)Risk Adjustment & Risk AssessmentClinical analyticsOperational analytics & administrative analyticsPopulation health analytics Healthcare Market, by End User Payer AnalyticsPrivate PayersPublic Payers & Government AgenciesEmployers Provider Hospitals, IDNs, and Physician PracticesPost-Acute Care OrganizationsAmbulatory Care Settings Accountable care organizations (ACOs) Healthcare Analytics Market, by Geography North America U.S. Canada Europe GermanyU.K. France Italy Spain Rest of Europe (RoE) Asia-Pacific China India Japan Rest of Asia-Pacific (RoAPAC) Rest of World (RoW)Latin America Middle East & Africa Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3995 Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.phpRelated Reports:Real World Evidence (RWE) Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) – Global Forecast to 2024https://www.meticulousresearch.com/product/Real-World-Evidence-Solutions-Market-4954/Population Health Management Solutions (PHM) Market by Component (Software, Service), Mode of Delivery (Web Based, On Premise, Cloud) and End User (Hospital, Clinic, Payor, Employer, Government, ACO) – Global Forecast to 2023https://www.meticulousresearch.com/product/population-health-management-solutions-phm-market/Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopaedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User – Global Forecast to 2023https://www.meticulousresearch.com/product/patient-registry-software-market/Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare) – Global Forecast to 2027https://www.meticulousresearch.com/product/healthcare-it-market-5084/Precision Medicine Software Market by Delivery Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) – Global Forecast to 2027https://www.meticulousresearch.com/product/precision-medicine-software-market-5011/About Meticulous Research®The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Mr. Khushal Bombe
Direct Lines: +1-646-781-8004 (North America)
+91 744-7780008 (Asia-Pacific)
Visit Our Website: https://www.meticulousresearch.com/
Meticulous Research® Blog: https://meticulousblog.org/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Latest News1 year ago
Bleckwen Raises $10m and Appoints David Christie as CEO
Artificial Intelligence1 year ago
Kneron Debuts Edge AI Chip, Bringing AI to Devices Everywhere
Artificial Intelligence1 year ago
Chartis Research Names FICO a Category Leader in AI for Financial Services
Artificial Intelligence1 year ago
CredoLab extends smartphone-based scoring to insurers
Artificial Intelligence1 year ago
LogRhythm Scores the Singapore Business Review Technology Excellence Award 2019 for Cyber Security – Computer Software
Artificial Intelligence1 year ago
Tuya Exhibiting Products from its Global Clients that are “Powered by Tuya”
Artificial Intelligence1 year ago
Chengdu Tianfu Software Park Reflects the Vitality of IP Innovation
Artificial Intelligence3 months ago
Special Report: Coronavirus and the Housing Industry